Journal article · 2022

Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors

Chunrong Yang, Yuchen Yang, Yujie Li, Qiankun Ni, Jinghong Li

Journal of the American Chemical Society, 145(1), 385–391 · Published 21 December 2022 · DOI 10.1021/jacs.2c10177

View at the publisherCite this paper

In brief

“Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors” is a 2022 journal article by Chunrong Yang and 4 co-authors, published in Journal of the American Chemical Society. OpenAlex counts 204 citations as of 19 November 2026, which puts it in the top 1% of works published in 2022 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
204
Most cited in
2025 (73)
Field-weighted impact
10.01
References
40
Authors
5

Abstract

Proteolysis targeting chimera (PROTAC) is an emerging protein degradation strategy, which shows excellent advantages in targeting those so-called “undruggable” proteins. However, the potential systemic toxicity of PROTACs caused by undesired off-tissue protein degradation may limit the application of PROTACs in clinical practice. Here we reported a radiotherapy-triggered PROTAC prodrug (RT-PROTAC) activation strategy to precisely and… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yang, C., Yang, Y., Li, Y., Ni, Q., & Li, J. (2022). Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors. Journal of the American Chemical Society, 145(1), 385–391. https://doi.org/10.1021/jacs.2c10177

MLA 9

Yang, Chunrong, et al. “Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors.” Journal of the American Chemical Society, vol. 145, no. 1, 2022, pp. 385–391. https://doi.org/10.1021/jacs.2c10177.

Chicago

Yang, Chunrong, Yuchen Yang, Yujie Li, Qiankun Ni, and Jinghong Li. 2022. “Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors.” Journal of the American Chemical Society 145 (1): 385–391. https://doi.org/10.1021/jacs.2c10177.

Harvard

Yang, C. et al. (2022) ‘Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors’, Journal of the American Chemical Society, 145(1), pp. 385–391. doi:10.1021/jacs.2c10177.

IEEE

C. Yang, Y. Yang, Y. Li, Q. Ni, and J. Li, “Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors,” Journal of the American Chemical Society, vol. 145, no. 1, pp. 385–391, 2022, doi: 10.1021/jacs.2c10177.

BibTeX

@article{yang2022radiotherapy,
  title     = {{Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors}},
  author    = {Yang, Chunrong and Yang, Yuchen and Li, Yujie and Ni, Qiankun and Li, Jinghong},
  journal   = {Journal of the American Chemical Society},
  year      = {2022},
  volume    = {145},
  number    = {1},
  pages     = {385--391},
  doi       = {10.1021/jacs.2c10177},
  url       = {https://doi.org/10.1021/jacs.2c10177}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20232727
20244747
20257373
20265757

Its field-weighted citation impact is 10.01: it has been cited 10.01 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • X-rays
  • bromodomain
  • BRD4
  • BRD2
  • protein degradation
  • spatiotemporal control
  • undruggable proteins

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Yang, C., Yang, Y., Li, Y., Ni, Q., & Li, J. (2022). Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors. Journal of the American Chemical Society, 145(1), 385–391. https://doi.org/10.1021/jacs.2c10177

How many times has this paper been cited?

204 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Chunrong Yang, Yuchen Yang, Yujie Li, Qiankun Ni, Jinghong Li.

What is the DOI of this paper?

10.1021/jacs.2c10177, permanently at https://doi.org/10.1021/jacs.2c10177. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.